Nyrada Inc. (ASX:NYR) Reports Half-Year Financial Results
Nyrada Inc. (ASX:NYR) reports a 64% revenue decline and a $2.46m loss for the half-year, while advancing its leading drug candidate to clinical trials.
The Hub of Australian Finance News
Nyrada Inc. (ASX:NYR) reports a 64% revenue decline and a $2.46m loss for the half-year, while advancing its leading drug candidate to clinical trials.
Bell Financial Group (ASX:BFG) reports a 26.4% increase in FY2024 profit and raises the dividend to 8.0 cents per share.
Ausmon Resources Limited (ASX:AOA) completes field traverses and prepares for rare earth drilling in South Australia’s Murray Basin.
Zelira Therapeutics (ASX:ZLD) secures a $1.15M refund under the R&D Tax Incentive Scheme to advance clinical programs and business operations.
Adriatic Metals (ASX:ADT) launches an A$80 million equity raising to accelerate the expansion of its Vares Silver Operation and enhance financial flexibility.
SG Fleet Group Limited (ASX:SGF) reports a 15.2% revenue increase in 1H25, with net profit after tax at $41.1 million.
Waratah Minerals (ASX:WTM) begins diamond drilling at the Spur Project, targeting high-priority porphyry mineralisation in New South Wales.
Power Minerals (ASX:PNN) completes first-phase drilling at Nióbio Project, Brazil, with significant pegmatite intercepts over 30m.
Tivan Limited (ASX:TVN) completes the acquisition of the Speewah Project, finalising its arrangements with KRR and setting the stage for a joint venture.
Adriatic Metals Plc (ASX:ADT) requests a trading halt pending a capital raising announcement to maintain market order.